Identification |
Name: | 4-({3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl}sulfonyl)morpholine |
Synonyms: | 4-[3-(5-p-Tolyl-[1,3,4]oxadiazol-2-yl)-benzenesulfonyl]-morpholine;morpholine, 4-[[3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]sulfonyl]- |
CAS: | 5915-64-0 |
Molecular Formula: | C19H19N3O4S |
Molecular Weight: | 385.4369 |
InChI: | InChI=1/C19H19N3O4S/c1-14-5-7-15(8-6-14)18-20-21-19(26-18)16-3-2-4-17(13-16)27(23,24)22-9-11-25-12-10-22/h2-8,13H,9-12H2,1H3 |
Molecular Structure: |
|
Properties |
Flash Point: | 314.4°C |
Boiling Point: | 596.3°C at 760 mmHg |
Density: | 1.32g/cm3 |
Refractive index: | 1.599 |
Flash Point: | 314.4°C |
Safety Data |
|
|